Abstract:Abstract Background and Aims It is widely known that chronic dialysis patients experience significantly higher cardiovascular (CV) death rates than the overall population. Among other CV risk factors, recent research has shown pulmonary hypertension (PH) as a consequence of chronic kidney disease and end-stage renal failure. The present study aimed to determine the risk factors that impact survival in chronic haemodialysis and peritoneal dialysis patients and to analyse the correlation of these factors with pulmonary hypertension. Method We studied 125 stable haemodialysis and peritoneal patients (females 40%, mean age 52.42 ±11.88 years) on RRT for more than three months with a two-year follow-up. Demographic information, clinical characteristics, blood tests, and a thorough echocardiographic evaluation were collected at the optimal dry weight. After conventional echocardiographic examination, a tissue Doppler echocardiographic (TDE) examination was performed to evaluate the global and regional myocardial systolic and diastolic functions and pulmonary hypertension. Systolic pulmonary artery pressure (sPAP) of 35 mmHg was used to define PH. Results The cardiovascular mortality rate was 15.5%. In ROC analysis for CV mortality, the area under the curve (AUC) for PH and CRP was found 0.8; for LVM-I, E/E', and PP, the AUC was 0.76, 0.75, 0.72, respectively, while the inverse relationship was found with MASa and TASa with AUC = 0.66 and 0.95 respectively. According to the echocardiographic findings, PH was found in 28% (35 patients) of all patients. The mean PH was 33.46±5.38 mmHg. The higher level of higher parathormone (PTH), C-reactive protein (CRP), and E/E’ average, the lower left ventricular ejection fraction (EF), the peak systolic velocity at the lateral mitral annulus (MASa), and the peak systolic velocity at the lateral tricuspid annulus (TASa) were found to be predictors of PH. Patients evaluated with PH have a significantly lower cardiovascular survival rate [Long Rank (Mantel-Cox) p = 0.0001. Conclusion Our research demonstrates that cardiovascular morbidity and death in dialysis patients are mainly attributed to pulmonary hypertension, inflammation, vascular stiffness, and left ventricular hypertrophy. PH is common among dialysis patients. Inflammation, CKD-MBD biomarkers linked to systolic and diastolic left and right ventricular dysfunction, and inflammation all influence it. These conditions are all connected. Cardiovascular imaging is simple to use, offers a favourable viewpoint in the early identification of cardiac abnormalities and quick treatment of this disease, and is thus strongly advised in the dialysis population.

Risk Factors for Pulmonary Hypertension in Patients Receiving Maintenance Peritoneal Dialysis

The related factors of pulmonary hypertension in peritoneal dialysis patients

The risk factors for pulmonary hypertension in peritoneal dialysis patients

The Influential Factor of Pulmonary Hypertension in Maintenance Hemodialysis Patients

A Combination of Clinical, Electrocardiographic, and Echocardiographic Parameters Predicts Pulmonary Hypertension Occurrence in Patients with End-Stage Renal Disease

Association of Pulmonary Hypertension with Mortality in Incident Peritoneal Dialysis Patients.

Pulmonary Hypertension Complicated by Pericardial Effusion on the Prognosis Among Maintenance Hemodialysis Patients

Pulmonary Hypertension in Hemodialysis Patients and Its Determinants: A Hospital Based Cross-Sectional Study

Prevalence and Risk Factors for Pulmonary Arterial Hypertension in End-Stage Renal Disease Patients Undergoing Continuous Ambulatory Peritoneal Dialysis.

#5221 PULMONARY HYPERTENSION: AN IMPORTANT RISK FACTOR IN CARDIOVASCULAR MORTALITY IN DIALYSIS PATIENTS

Risk factors of mortality in patients on maintenance peritoneal dialysis with high peritoneal transport status

The Associations of Blood Pressure Parameters with All-Cause and Cardiovascular Mortality in Peritoneal Dialysis Patients: a Cohort Study in China.

Epidemiology and risk factors in CKD patients with pulmonary hypertension: a retrospective study

Burden of Pulmonary Hypertension in End-Stage Renal Disease Patients Receiving Maintenance Hemodialysis: Evaluation Factors and Treatment Strategies

Risk Factors of Cardiac Complications in Patients with End-Stage Renal Disease Undergoing Maintenance Peritoneal Dialysis

Associations of Mean Arterial Pressure Levels with Mortality in Patients with Peritoneal Dialysis

Association of Pulmonary Hypertension With Inflammatory Markers and Volume Status in Hemodialysis Patients of End-Stage Renal Disease

Associations Between Home Blood Pressure and Mortality in Peritoneal Dialysis

Determinants of Pulmonary Hypertension in Patients with End-stage Kidney Disease and Arteriovenous Access

Prevalence and Risk Factors for Peripheral Artery Disease among Patients on Maintenance Peritoneal Dialysis.

[End-Stage Renal Disease and Pulmonary Hypertension].